ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWOU
2U Inc
TWOU
|
+$87.8M |
| 2 |
XYZ
Block Inc
XYZ
|
+$62.3M |
| 3 |
Illumina
ILMN
|
+$47.8M |
| 4 |
LendingTree
TREE
|
+$41.7M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$37.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$91M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$70.8M |
| 3 |
Spotify
SPOT
|
+$63.6M |
| 4 |
Baidu
BIDU
|
+$53.5M |
| 5 |
NVTA
Invitae Corporation
NVTA
|
+$37.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.39% |
| 2 | Technology | 20.66% |
| 3 | Consumer Discretionary | 8.68% |
| 4 | Communication Services | 6.26% |
| 5 | Financials | 3.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Netflix
NFLX
$307B
| $37.8M | 0.82% |
1,410,830
+234,550
| +20% | +$7.34M |
|
27
Compugen
CGEN
$218M
| $36.8M | 0.8% |
8,691,317
+194,676
| +2% | +$728K |
|
28
Aptiv
APTV
$9.61B
| $34.6M | 0.75% |
395,575
+319,838
| +422% | +$26.7M |
|
29
Autodesk
ADSK
$51.2B
| $29.7M | 0.65% |
201,258
+168,411
| +513% | +$26.2M |
|
30
Roku
ROKU
$22.3B
| $29.4M | 0.64% |
289,270
+211,845
| +274% | +$25.9M |
|
|
EB
31
DELISTED
Eventbrite
EB
| $29.4M | 0.64% |
1,660,664
+12,887
| +0.8% | +$226K |
|
32
Seres Therapeutics
MCRB
$47.9M
| $28.4M | 0.62% |
353,748
+1,804
| +0.5% | +$119K |
|
33
Trade Desk
TTD
$8.31B
| $26.9M | 0.59% |
+1,434,850
| New | +$34.1M |
|
34
Alibaba
BABA
$304B
| $22.4M | 0.49% |
133,930
-18,229
| -12% | -$3.13M |
|
35
Mercado Libre
MELI
$92.8B
| $20.9M | 0.46% |
37,911
+23,244
| +158% | +$14.1M |
|
|
XONE
36
DELISTED
The ExOne Company
XONE
| $20.4M | 0.44% |
2,301,775
-2,779
| -0.1% | -$22.7K |
|
|
CLDR
37
DELISTED
Cloudera, Inc.
CLDR
| $18.4M | 0.4% |
2,079,484
-464,892
| -18% | -$3.23M |
|
38
Apple
AAPL
$4.56T
| $18.4M | 0.4% |
328,676
-29,332
| -8% | -$1.53M |
|
39
Amazon
AMZN
$2.94T
| $16.8M | 0.37% |
193,160
-30,500
| -14% | -$2.83M |
|
40
Bristol-Myers Squibb
BMY
$131B
| $16.3M | 0.36% |
320,712
-31,709
| -9% | -$1.49M |
|
41
Iovance Biotherapeutics
IOVA
$2.77B
| $14.8M | 0.32% |
814,796
+7,108
| +0.9% | +$157K |
|
42
Pinduoduo
PDD
$129B
| $14.7M | 0.32% |
455,251
-212,309
| -32% | -$5.67M |
|
|
43
Baidu
BIDU
$37.1B
| $13.8M | 0.3% |
134,268
-497,692
| -79% | -$53.5M |
|
44
Arcturus Therapeutics
ARCT
$173M
| $13.1M | 0.29% |
1,274,413
+270,045
| +27% | +$2.92M |
|
|
CLLS
45
Cellectis
CLLS
$271M
| $12.9M | 0.28% |
1,239,863
+136,677
| +12% | +$1.84M |
|
46
Ionis Pharmaceuticals
IONS
$9.06B
| $11.8M | 0.26% |
196,669
+38,896
| +25% | +$2.54M |
|
47
Regeneron Pharmaceuticals
REGN
$79.5B
| $11.1M | 0.24% |
40,073
+11,480
| +40% | +$3.4M |
|
48
AeroVironment
AVAV
$8.66B
| $9.6M | 0.21% |
179,242
-2,534
| -1% | -$139K |
|
49
Incyte
INCY
$24B
| $9.22M | 0.2% |
124,229
-6,508
| -5% | -$526K |
|
50
Inovio Pharmaceuticals
INO
$69.6M
| $8.66M | 0.19% |
351,891
+22,306
| +7% | +$678K |
|
Similar funds
ARK Investment Management's Q3 2019 Portfolio in Review
As of Q3 2019, ARK Investment Management held 246 positions worth $4.58B, up 15% from $3.97B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
ARK Investment Management deployed $889M of net new capital in Q3 2019, opening 39 new positions and adding to 84 existing holdings. Its largest new stake was Trade Desk: 1,434,850 shares worth $26.9M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $91M trimmed.
- ARK Investment Management's largest Q3 2019 buy was Trade Desk: 1,434,850 shares worth $26.9M.
- ARK Investment Management added most to 2U Inc in Q3 2019, an estimated $87.8M increase.
- ARK Investment Management's biggest Q3 2019 reduction was NVIDIA, cutting an estimated $91M.
- ARK Investment Management fully exited Jumia Technologies in Q3 2019, selling an estimated $7.21M.
- ARK Investment Management's ten largest holdings make up 44% of its $4.58B portfolio in Q3 2019.
- ARK Investment Management opened 39 new positions and closed 24 in Q3 2019.
- ARK Investment Management's portfolio value rose 15% quarter-over-quarter to $4.58B.
Based on ARK Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.